These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 16140015)
21. Synthesis and antibacterial activity of arylpiperazinyl oxazolidinones with diversification of the N-substituents. Jang SY; Ha YH; Ko SW; Lee W; Lee J; Kim S; Kim YW; Lee WK; Ha HJ Bioorg Med Chem Lett; 2004 Aug; 14(15):3881-3. PubMed ID: 15225689 [TBL] [Abstract][Full Text] [Related]
22. Molecular design of anti-MRSA agents based on the anacardic acid scaffold. Green IR; Tocoli FE; Lee SH; Nihei K; Kubo I Bioorg Med Chem; 2007 Sep; 15(18):6236-41. PubMed ID: 17601740 [TBL] [Abstract][Full Text] [Related]
27. N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria. Opoku-Temeng C; Naclerio GA; Mohammad H; Dayal N; Abutaleb NS; Seleem MN; Sintim HO Eur J Med Chem; 2018 Jul; 155():797-805. PubMed ID: 29957525 [TBL] [Abstract][Full Text] [Related]
28. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series. Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097 [TBL] [Abstract][Full Text] [Related]
29. Aryldiketo acids have antibacterial activity against MDR Staphylococcus aureus strains: structural insights based on similarity and molecular interaction fields. Drakulić BJ; Stavri M; Gibbons S; Zizak ZS; Verbić TZ; Juranić IO; Zloh M ChemMedChem; 2009 Dec; 4(12):1971-5. PubMed ID: 19856377 [No Abstract] [Full Text] [Related]
30. Discovery of a biologically active thiostrepton fragment. Nicolaou KC; Zak M; Rahimipour S; Estrada AA; Lee SH; O'Brate A; Giannakakou P; Ghadiri MR J Am Chem Soc; 2005 Nov; 127(43):15042-4. PubMed ID: 16248640 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives. Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationships of 2-vinylchroman-4-ones as potent antibiotic agents. Albrecht U; Lalk M; Langer P Bioorg Med Chem; 2005 Mar; 13(5):1531-6. PubMed ID: 15698769 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria. Lu J; Yoshida O; Hayashi S; Arimoto H Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629 [TBL] [Abstract][Full Text] [Related]
34. Simple dihydrosphyngosine analogues with potent activity against MDR-Mycobacterium tuberculosis. Del Olmo E; Molina-Salinas GM; Escarcena R; Alves M; López-Pérez JL; Hernandez-Pando R; Said-Fernández S; Feliciano AS Bioorg Med Chem Lett; 2009 Oct; 19(19):5764-8. PubMed ID: 19703769 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents. Hu L; Kully ML; Boykin DW; Abood N Bioorg Med Chem Lett; 2009 Mar; 19(5):1292-5. PubMed ID: 19208475 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-antibacterial activity relationship investigation of isomeric 2,3,5-substituted perhydropyrrolo[3,4-d]isoxazole-4,6-diones. Agirbas H; Guner S; Budak F; Keceli S; Kandemirli F; Shvets N; Kovalishyn V; Dimoglo A Bioorg Med Chem; 2007 Mar; 15(6):2322-33. PubMed ID: 17276071 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of bis, tris and tetra(dihydrocaffeoyl)polyamine conjugates as antibacterial agents against VRSA. Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A Arch Pharm Res; 2008 Jun; 31(6):698-704. PubMed ID: 18563350 [TBL] [Abstract][Full Text] [Related]
39. The post-antibiotic effects of linezolid against Gram-positive pathogens. Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476 [TBL] [Abstract][Full Text] [Related]
40. Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins. Li J; Ma Z; Chapo K; Yan D; Lynch AS; Ding CZ Bioorg Med Chem Lett; 2007 Oct; 17(20):5510-3. PubMed ID: 17826091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]